Fig. 3From: Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysisForest plot and meta-analysis of visual clarity. (a) Incidence of chemotherapy dose reduction or delays. (b) Requirement of platelet transfusion. (c) Incidence of hemorrhagic eventsBack to article page